Shortage reports
Actual shortage:
58 (4%)
Anticipated shortage:
2 (0%)
Avoided shortage:
37 (3%)
Resolved:
1273 (93%)
1370
Discontinuation Reports
To be discontinued:
2 (1%)
Discontinued:
287 (99%)
Reversed:
2 (1%)
291
211 (13%)
10 (16%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| PMS-BICALUTAMIDE | 50MG | TABLET | Resolved | 2023-04-14 | 2023-06-21 | 189587 |
| PMS-BICALUTAMIDE | 50MG | TABLET | Resolved | 2023-04-14 | 2023-06-07 | 189584 |
| PMS-BICALUTAMIDE | 50MG | TABLET | Resolved | 2017-04-07 | 2018-06-07 | 6105 |
| PMS-BICALUTAMIDE | 50MG | TABLET | Resolved | 2017-04-20 | 2018-06-29 | 7338 |
| PMS-BISACODYL | 10MG | SUPPOSITORY | Resolved | 2017-05-04 | 2020-06-10 | 8919 |
| PMS-BOSENTAN | 125MG | TABLET | Resolved | 2017-12-07 | 2018-02-17 | 32035 |
| PMS-BRIMONIDINE | 0.2% | SOLUTION | Resolved | 2017-03-13 | 2020-04-02 | 1774 |
| PMS-BUPRENORPHINE-NALOXONE | 2MG 0.5MG | TABLET | Resolved | 2019-06-11 | 2019-07-03 | 86234 |
| PMS-BUPRENORPHINE-NALOXONE | 2MG 0.5MG | TABLET | Avoided shortage | 2019-03-29 | 2019-05-01 | 79878 |
| PMS-BUPRENORPHINE-NALOXONE | 0.5MG 2MG | TABLET | Resolved | 2024-07-24 | 2024-10-09 | 233605 |
| PMS-BUPRENORPHINE-NALOXONE | 8MG 2MG | TABLET | Resolved | 2017-08-01 | 2017-11-23 | 17805 |
| PMS-BUPRENORPHINE-NALOXONE | 8MG 2MG | TABLET | Resolved | 2019-05-09 | 2019-07-30 | 83732 |
| PMS-BUPRENORPHINE-NALOXONE | 8MG 2MG | TABLET | Resolved | 2019-10-04 | 2022-01-17 | 95445 |
| PMS-BUPRENORPHINE-NALOXONE | 8MG 2MG | TABLET | Resolved | 2019-06-28 | 2019-07-30 | 88025 |
| PMS-BUPRENORPHINE-NALOXONE | 2MG 0.5MG | TABLET | Resolved | 2017-03-14 | 2017-11-23 | 2352 |
| PMS-BUSPIRONE | 10MG | TABLET | Resolved | 2017-05-04 | 2017-07-19 | 8925 |
| PMS-BUSPIRONE | 10MG | TABLET | Resolved | 2017-08-11 | 2018-05-05 | 18860 |
| PMS-CANDESARTAN | 16MG | TABLET | Resolved | 2019-11-15 | 2020-06-10 | 98796 |
| PMS-CANDESARTAN | 32MG | TABLET | Resolved | 2023-08-10 | 2023-09-18 | 201545 |
| PMS-CANDESARTAN | 16MG | TABLET | Resolved | 2019-11-15 | 2020-06-10 | 98799 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| AC&C TABLETS | 375MG 8MG 15MG | TABLET | Discontinued | 2017-03-31 | 2017-03-31 | 4993 |
| AC&C TABLETS | 375MG 8MG 15MG | TABLET | Discontinued | 2017-03-31 | 2017-03-31 | 4990 |
| AC&C TABLETS | 375MG 8MG 15MG | TABLET | Discontinued | 2017-04-07 | 2017-04-07 | 6035 |
| AC&C TABLETS | 375MG 8MG 15MG | TABLET | Discontinued | 2017-04-07 | 2017-04-07 | 6031 |
| ACET CODEINE 30 | 300MG 30MG | TABLET | Discontinued | 2018-02-22 | 2018-07-23 | 40586 |
| ACET CODEINE 60 | 300MG 60MG | TABLET | Discontinued | 2019-01-16 | 2019-01-17 | 72608 |
| ACETAMINOPHEN, CAFFEINE & CODEINE | 8MG 15MG 300MG | TABLET | Discontinued | 2020-06-15 | 2021-10-27 | 117748 |
| ACETAMINOPHEN, CAFFEINE & CODEINE | 300MG 8MG 15MG | TABLET | Discontinued | 2017-10-12 | 2017-10-13 | 25698 |
| ACETAMINOPHEN, CAFFEINE & CODEINE | 300MG 8MG 15MG | TABLET | Discontinued | 2017-10-12 | 2017-10-13 | 25692 |
| ACETAMINOPHEN, CAFFEINE & CODEINE | 300MG 15MG 8MG | TABLET | Discontinued | 2020-06-15 | 2021-10-27 | 117751 |
| ATORVASTATIN | 80MG | TABLET | Discontinued | 2021-04-23 | 2021-04-23 | 138001 |
| ATORVASTATIN | 10MG | TABLET | Discontinued | 2021-04-23 | 2021-04-23 | 137982 |
| ATORVASTATIN | 40MG | TABLET | Discontinued | 2021-04-23 | 2021-04-23 | 137995 |
| ATORVASTATIN | 10MG | TABLET | Discontinued | 2021-04-23 | 2021-04-23 | 137986 |
| ATORVASTATIN | 20MG | TABLET | Discontinued | 2021-04-23 | 2021-04-23 | 137992 |
| ATORVASTATIN | 40MG | TABLET | Discontinued | 2021-04-23 | 2021-04-23 | 137998 |
| ATORVASTATIN | 20MG | TABLET | Discontinued | 2021-04-23 | 2021-04-23 | 137989 |
| ATORVASTATIN | 20MG | TABLET | Discontinued | 2020-07-23 | 2020-07-23 | 120976 |
| CHARCODOTE SUSP 200MG/ML | 200MG | SUSPENSION | Discontinued | 2020-06-16 | 2020-06-16 | 118017 |
| EGOZINC-HC | 0.5% 0.5% | OINTMENT | Discontinued | 2018-01-26 | 2018-01-26 | 37263 |